Mr. Assad Jalil is a Consultant Ophthalmologist, Vitreoretinal and
Cataract Surgeon and Uveitis Specialist.
He is the Lead Clinician of Vitreoretinal Surgery at Manchester Royal Eye
Hospital, one of the leading ophthalmic units of Europe, and a centre for
clinical and research excellence.
He is also the UK Professional Standards Lead for British and Eire
Association of Vitreoretinal Surgeons (BEAVRS).
Mr. Jalil has extensive experience in all aspects of latest vitreoretinal
surgery including 23G, 25G and 27G pars plana vitrectomies. He has a
special interest in surgical and medical management of vitreous and retinal
diseases including retinal detachment; diabetic retinopathy; macular diseases
including macular hole and epiretinal membranes; floaters; retinal vein
occlusions; and age-related macular degeneration (including the use of
intravitreal anti-VEGF injections). His surgical expertise also encompasses
simple and complex cataract surgery as well as dealing with complications
of cataract surgery. In addition, he is an expert of complex, sight-
threatening ocular inflammatory disorders (uveitis) especially in the use
of immunosuppressive medications and vitrectomy in dealing with this
condition. He regularly audits his practice to ensure the highest standards of
quality of care.
In addition to his clinical expertise, Mr. Jalil is an integral part of the research
team at Manchester Royal Eye Hospital which has pioneered research into,
amongst others, retinal implants and retinal gene therapy. He is one of the
few retinal surgeons in the world performing retinal gene therapy.
Mr. Jalil has co-authored 3 book chapters in addition to more than 50
publications in peer-reviewed ophthalmic journals. He regularly presents at
national and international meetings. He is the supervisor of the well renowned
Clinical as well as the Research Vitreoretinal fellowships at Manchester Royal
Eye Hospital, and is involved in training surgeons from all over the world.